Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
This study has been terminated.
(FDA Hold May 2007)
Sponsor:
Point Therapeutics
Information provided by:
Point Therapeutics
ClinicalTrials.gov Identifier:
NCT00116389
First received: June 28, 2005
Last updated: June 7, 2007
Last verified: June 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |